119 related articles for article (PubMed ID: 3323072)
21. [Control of hypertension and blood lactate during exercise. Comparison of central antihypertensive agents with the cardio-selective beta blockers metoprolol and atenolol].
Hardin JM; Andrejak M; Makdassi R; Gherbrand JD; Fievet P; Schmit JL; Roger JC; Harichaux P; Kassouf J; Fournier A
Arch Mal Coeur Vaiss; 1981 Jun; 74 Spec No():117-24. PubMed ID: 6117261
[TBL] [Abstract][Full Text] [Related]
22. Metoprolol in high renin hypertension. A comparison with propranolol.
Lameyer LD; Hesse CJ
Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
[TBL] [Abstract][Full Text] [Related]
23. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone.
Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A
Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689
[TBL] [Abstract][Full Text] [Related]
24. A comparative trial of ordinary metoprolol tablets and metoprolol sustained-release tablets in hypertensive patients at rest and on exercise.
Witchitz S; Moisson P; Kolsky H
Pharmatherapeutica; 1984; 3(8):566-72. PubMed ID: 6366811
[TBL] [Abstract][Full Text] [Related]
25. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
[TBL] [Abstract][Full Text] [Related]
26. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
27. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
[TBL] [Abstract][Full Text] [Related]
28. Sustained release metoprolol: a comparison with conventional formulation in the treatment of hypertension.
Logan RL; Goldstraw PW; Kiddle GB; Flacks LM; Watt M
N Z Med J; 1981 Jul; 93(687):1-2. PubMed ID: 7022275
[TBL] [Abstract][Full Text] [Related]
29. Antihypertensive activity of alpha-methyldopa on a twice daily regimen in comparison to metoprolol. A multi-centre controlled clinical trial.
Muiesan G; Agabiti-Rosei E; Alicandri C; Motolese M
Clin Exp Pharmacol Physiol Suppl; 1978; 4():35-41. PubMed ID: 354827
[TBL] [Abstract][Full Text] [Related]
30. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
31. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I
Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854
[TBL] [Abstract][Full Text] [Related]
32. [Assessment of the efficacy and tolerance of delayed-action nifedipine as the monotherapy or in combination with metoprolol in patients with arterial hypertension].
Isaĭkina OIu; Gorbunov VM; Andreeva GF; Dmitrieva NA; Martsevich SIu
Ter Arkh; 2003; 75(12):39-43. PubMed ID: 14959468
[TBL] [Abstract][Full Text] [Related]
33. The effect of prindolol on plasma noradrenaline, plasma renin and sodium-potassium metabolism in patients with essential hypertension.
Brecht HM; Werner E; Schoeppe W
Adv Clin Pharmacol; 1976; 11():66-9. PubMed ID: 1032572
[TBL] [Abstract][Full Text] [Related]
34. [Antihypertensive treatment with metoprolol: haemodynamic reactions in hypertensives with normal left ventricular function (author's transl)].
Patyna WD
Dtsch Med Wochenschr; 1982 Apr; 107(15):584-7. PubMed ID: 7067639
[TBL] [Abstract][Full Text] [Related]
35. Acute haemodynamic effect of metoprolol in essential hypertension.
Pechán J; Mikulecký M; Srbecký M
Cor Vasa; 1988; 30(1):51-9. PubMed ID: 3132353
[TBL] [Abstract][Full Text] [Related]
36. Metoprolol or hydrochlorothiazide in patients with hypertension aged 60-75 years. With special reference to assessment of compliance. Hunter Hypertension Research Group.
Med J Aust; 1986 Nov; 145(10):521-3. PubMed ID: 2877386
[TBL] [Abstract][Full Text] [Related]
37. Does hormone analysis predict the antihypertensive response of basic medical treatment?
Witzgall H; Scherer B; Lange HH; Weber PC
Herz; 1989 Jun; 14(3):197-203. PubMed ID: 2661389
[TBL] [Abstract][Full Text] [Related]
38. Ketanserin versus metoprolol in the treatment of essential hypertension.
Milei J; Lemus J; Bernardiner E
J Hypertens Suppl; 1986 Apr; 4(1):S77-9. PubMed ID: 2939218
[TBL] [Abstract][Full Text] [Related]
39. Ketanserin in the treatment of essential hypertension. A double-blind study against metoprolol and a further long-term open treatment.
Milei J; Lemus J; Bernardiner E
Acta Cardiol; 1986; 41(6):427-41. PubMed ID: 3544622
[TBL] [Abstract][Full Text] [Related]
40. [Graded physical loading in assessing the efficacy of hypotensive pharmacotherapy].
Anshelevich IuV; Gersamiia AG
Ter Arkh; 1991; 63(4):37-40. PubMed ID: 2068676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
